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Abstract
A 56 year old aromatherapist presented with advanced renal failure following chronic coal tar
creosote vapour inhalation, and a chronic tubulo-interstitial nephritis was identified on renal
biopsy. Following dialysis dependence occult inhalation continued, resulting in seizures, ataxia,
cognitive impairment and marked generalised cerebral atrophy. We describe for the first time a
case of creosote abuse by chronic vapour inhalation, resulting in significant morbidity. Use of the
polycyclic aromatic hydrocarbon-containing wood preservative coal tar creosote is restricted by
many countries due to concerns over environmental contamination and carcinogenicity. This case
demonstrates additional toxicities not previously reported with coal tar creosote, and emphasizes
the health risks of polycyclic aromatic hydrocarbon exposure.
Background
Coal Tar Creosotes are distillation products of coal tar
widely used for preserving wood. Creosotes pose a health
risk due to carcinogenicity, and are banned from commer-
cial use in many countries. The European Union banned
the commercial sale of creosotes in 2003. Creosote vola-
tiles are complex, consisting of almost 300 different com-
pounds [1]. However, creosote abuse by vapour
inhalation has never been described.
Case Report
A 56 year old aromatherapist presented with advanced
renal impairment (Blood Urea 26.1 mmol/l, Creatinine
704 μmol/l). She had been fatigued with general malaise
for the preceding three months, but denied any constitu-
tional symptoms. She had developed modest nocturia,
but had no other lower urinary tract symptoms. She had
been previously healthy, and denied the use of any medi-
cations or herbal remedies.
Physical examination revealed pallor, hypertension
(Supine BP 210/110) and euvolumia, no mucocutaneous
lesions, and no uveitis. Urine analysis was positive for
protein on stick testing, with negative microscopy. Full
Blood Count at presentation confirmed normocytic nor-
mochromic anaemia, without eosinophilia. A renal tract
ultrasound was performed, and revealed normal sized
unobstructed kidneys.
Renal biopsy showed a 9 mm core of renal cortex in which
the glomeruli and vasculature did not exhibit any signifi-
cant abnormality. By contrast there was diffuse and strik-
ing cortical tubular atrophy with evidence of ongoing
epithelial shedding (Fig. 1). The tubular epithelium was
markedly attenuated to the point where proximal and dis-
tal tubules were not reliably distinguishable. Tubular cells
showed occasional apoptosis, increased nuclear variabil-
ity, scattered tubules showed cytoplasmic vacuolisation,
and occasional cells showed cytoplasmic lipochrome pig-
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ment. Tubular basement membranes were thickened and
wrinkled. The cortical tubules were widely separated by an
expanded, rather pauci-cellular interstitial matrix in
which sparse small lymphocytes, macrophages and occa-
sional eosinophils were evident. No kidney was present in
the immunofluorescence sample, but electron micros-
copy showed a glomerulus with only mildly expanded
mesangial matrix, mild wrinkling of the basement mem-
brane, no immune complex deposits or podocyte foot
process fusion. No immune deposits were evident in the
interstitium on electron microscopy. It was concluded
that the biopsy showed a chronic low grade interstitial
nephropathy that was suggestive of a toxin-induced proc-
ess. Despite re-interrogation of the patient, exposure to all
known nephrotoxins was denied. The patient received a
trial of oral steroid therapy but failed to improve and
commenced regular haemodialysis four months later.
Fifteen months after commencing haemodialysis, the
patient was readmitted to the emergency unit with
increasing confusion. Admission was followed with three
short generalized seizures terminated by intravenous
diazepam, with a prolonged depressed level of concious-
ness post-ictally. As metabolic causes for seizures had
been excluded, a Computerised Tomogram (CT) of the
head was performed. This did not identify a cause for sei-
zures, but revealed significant cerebral atrophy deemed
out of keeping for the patient's age. Magnetic Resonance
Imaging (MRI) confirmed cerebral atrophy, and addition-
ally identified subtle deep white matter changes.
Renal biopsy specimen obtained at the time of clinical presentation with advanced renal impairment Figure 1
Renal biopsy specimen obtained at the time of clinical presentation with advanced renal impairment. There is severe tubular 
atrophy and interstitial changes consistent with an advanced chronic interstitial nephropathy. A) Low power haematoxylin and 
eosin stain demonstrating chronic interstitial nephropathy. B) High power view indicating tubular debris within the nephron 
lumen (arrowed). C) High power view demonstrating marked tubular cell vacuolisation. D) PAS stain demonstrating thickened 
basement membrane and marked cytoplasmic lypochrome pigmentation.
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Following treatment with intravenous phenytoin she suf-
fered no further seizures though she remained comatose
for three days, recovering slowly thereafter. At this time,
examination revealed proximal muscle weakness, ataxia, a
wide-based gait, blunted affect, and evidence of memory
impairment.
A period of in-hospital rehabilitation was followed by a
home visit with an occupational therapist, at which time
the patient was witnessed to inhale creosote vapour from
a container filled with coal tar creosote and kept on a
kitchen shelf for this sole purpose. Upon interrogation
she admitted inhaling creosote vapour daily and often for
at least 6 years prior to the first hospital admission, fre-
quently carrying a concealed supply on her person when
venturing from home. Indeed, a neighbour had surrepti-
tiously provided her with a creosote-impregnated cloth in
a sealed sandwich container, facilitating continued uni-
dentified inhalation during her inpatient stay.
Further progression of her neurological condition was evi-
denced by the subsequent development of dementia over
a period of months.
Discussion
Inhalant substance abuse is widespread, typically involv-
ing the inhalation of glue, spray paint, petroleum, correc-
tion fluid, nail polish remover or dry cleaning fluid by
adolescents. Polycyclic Aromatic Hydrocarbons (PAHs)
are common to these substances, and their inhalation has
multiple toxicities. As all these compounds contain a vari-
ety of different PAHs, it is impossible to determine the
individual toxicity of any particular PAH. Coal Tar Creo-
sotes likewise contain many PAHs, and creosote vapour
includes naphthalene, acenaphthene, fluorene, phenan-
threne, anthracene, fluoranthene and pyrene among
many others. All of these are detectable in urine following
inhalation exposure, with naphthalene being the most
abundant [2]. Here we describe the first case of creosote
misuse by vapour inhalation.
Nephrotoxicity
PAH exposure is associated with a higher risk of renal dys-
function and renal cancer. A large body of evidence con-
firms nephrotoxicity with chronic exposure to PAHs [3],
and experimental data have demonstrated both glomeru-
lar and tubular toxicity [4].
Specific data on the renal effects of creosote vapour inha-
lation are limited, although animal studies suggest renal
toxicity. Systemic exposure by inhalation has been dem-
onstrated by detection of the pyrene metabolite 1-hydrox-
ypyrene in urine of exposed subjects [5]. In an
experimental model of coal tar creosote (CTC) vapour
exposure, Springer et al observed pigmentation of tubular
epithelial cells, proliferation of urothelium, and a signifi-
cant increase in BUN concentrations [6]. In a cross-sec-
tional study by the Tabershaw Occupational Medicine
Associates (TOMA 1981), wood factory workers exposed
to creosote had an increased incidence of haematuria, red
cell- and granular casts, although renal function of this
cohort was not documented. Interestingly this group also
noted eosinophilia in 8% of workers.
The smallest and most volatile component in creosote is
naphthalene, the principal ingredient of moth balls.
Addiction to naphthalene inhalation has been reported,
and naphthalene exposure has been associated with
chronic renal failure [7].
Mechanistically, a number of factors may contribute to
the nephrotoxicity observed with hydrocarbon exposure,
as reviewed by Ravnskov [3]. First, hydrocarbons may
induce renal injury by combining with renal proteins and
acting as haptens to induce auto-immunity against renal
cells. Second, hydrocarbons may modify T-cell function
leading to an unfavourable cytokine profile and predis-
posing to T-cell mediated renal injury. This hypothesis is
supported by the abrogation of renal injury in animal
models by glucocorticoid pretreatment. Third, animal
studies demonstrating an effect of species and sex on sus-
ceptibility implicate the importance of genetic and hor-
monal susceptibility.
Neurotoxicity
Volatile hydrocarbons are rapidly taken up into the circu-
lation, and are sequestered in adipose tissues. Uptake by
neurons is particularly rapid, accounting for the rapid
'high' often experienced with inhalant abuse. Subsequent
excretion of PAHs or their metabolites occurs via urine,
bile and feces. Inhalation of substances containing PAHs
have been associated with confusion, disorientation, nys-
tagmus, ataxia, cerebellar degeneration, tremor, white
matter degeneration, memory loss, dementia and seizures
[8], and there is in vitro evidence for a direct neurotoxic
effect of many PAHs present in creosote vapour [9].
However, direct neurotoxicity from creosote vapour inha-
lation has to our knowledge not been described before. It
is important to note that our patient was exposed to creo-
sote vapour for many years prior to presentation, and neu-
rotoxicity prior to dialysis dependence had not been overt.
Reports of patients with end stage renal failure due to
chronic PAH inhalation do not give the total exposure lev-
els, and so its effects in this population are unknown.
As our patient had become oligo-anuric over the initial 18
months of dialysis dependence, we hypothesize a suscep-
tibility to neurotoxicity in this individual due to a
decreased renal excretion of PAHs and their metabolites.Publish with BioMed Central    and   every 
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The neurological signs were similar to that described with
inhalant abuse of other aromatic hydrocarbons like tolu-
ene [10], including ataxia, gait disturbance, seizures, gen-
eralized cerebral atrophy and deep white matter changes.
Conclusion
Taken together, the clinical findings of this case and cur-
rent understanding of PAH toxicities strongly implicate
creosote vapour inhalation as the cause of this woman's
clinical presentation. The ultrasound findings of 'normal
sized kidneys' is perhaps unusual for a chronic interstitial
nephritis. It is the case, however, that ultrasonographic
estimation of renal size by ultrasound may vary by ~1.6
cm between operators or scans [11] and the histological
picture indicates chronic kidney damage. Although cau-
sality remains unproven and most histological features
are common to any toxin-induced interstitial nephritis,
the cytoplasmic pigmentation of renal tubular cells iden-
tified on renal biopsy is unusual and congruent with
experimental data [6].
As is often the case with inhalant abuse, this diagnosis
proved difficult to establish despite repeatedly question-
ing the patient. Study of urinary hydrocarbons or tubular
protein excretion was not undertaken as vapour inhala-
tion was not noted until the patient was dialysis depend-
ent and anuric. Nevertheless our contention that the
creosote inhalation was instrumental to the pathogenesis
of chronic renal failure is supported by an increasing body
of evidence implicating PAH exposure in the development
and progression of renal disease. This notion has implica-
tions for the significance of occupational exposure to
PAHs. Our findings imply an occupational health merit in
monitoring renal function in workers chronically exposed
to coal tar and its volatiles, a requirement further sup-
ported by the possible increased risk of extra-renal toxicity
in subjects with pre-existing renal impairment.
Finally, this case highlights the often-underestimated
value of assessing patients in the home environment.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
TH was responsible for the care of the patient during
admissions, and drafted the manuscript. JH was responsi-
ble for the patient's management, contributed to the intel-
lectual content, and proof read the manuscript. CB
reviewed the renal biopsy samples, contributed intellec-
tual content and photograph, and proof read the manu-
script.
Acknowledgements
The authors wish to thank Joanna Quinn who conducted a home visit as the 
patient's occupational therapist, and identified the creosote inhalation.
References
1. Guillen MD, Iglesias MJ, Dominguez A, Blanco CG: Polynuclear aro-
matic hydrocarbon retention indices on SE-54 stationary
phase of the volatile components of a coal tar pitch: Rela-
tionships between chromatographic retention and thermal
reactivity.  J Chromatogr 1992, 591:287-295.
2. Campo L, Addario L, Buratti M, Scibetta L, Longhi O, Valla C, Cirla
PE, Martinotti I, Foa V, Fustinoni S: Biological monitoring of expo-
sure to polycyclic aromatic hydrocarbons by determination
of unmetabolized compounds in urine.  Toxicology letters 2006,
162(2-3):132-138.
3. Ravnskov U: Experimental glomerulonephritis induced by
hydrocarbon exposure: a systematic review.  BMC nephrology
2005, 6:15.
4. Nanez A, Alejandro NF, Falahatpisheh MH, Kerzee JK, Roths JB,
Ramos KS: Disruption of glomerular cell-cell and cell-matrix
interactions in hydrocarbon nephropathy.  American journal of
physiology 2005, 289(6):F1291-303.
5. Elovaara E, Heikkila P, Pyy L, Mutanen P, Riihimaki V: Significance of
dermal and respiratory uptake in creosote workers: expo-
sure to polycyclic aromatic hydrocarbons and urinary excre-
tion of 1-hydroxypyrene.  Occupational and environmental medicine
1995, 52(3):196-203.
6. Springer DL, Miller RA, Weimer WC, Ragan HA, Buschbom RL,
Mahlum DD: Effects of inhalation exposure to high-boiling
(288-454 degrees C) coal liquid.  Toxicol Appl Pharmacol 1986,
82(1):112-131.
7. Weintraub E, Gandhi D, Robinson C: Medical complications due
to mothball abuse.  Southern medical journal 2000, 93(4):427-429.
8. Brouette T, Anton R: Clinical review of inhalants.  The American
journal on addictions / American Academy of Psychiatrists in Alcoholism and
Addictions 2001, 10(1):79-94.
9. Tang Y, Donnelly KC, Tiffany-Castiglioni E, Mumtaz MM: Neurotox-
icity of polycyclic aromatic hydrocarbons and simple chemi-
cal mixtures.  Journal of toxicology and environmental health 2003,
66(10):919-940.
10. Lolin Y: Chronic neurological toxicity associated with expo-
sure to volatile substances.  Human toxicology 1989, 8(4):293-300.
11. Widjaja E, Oxtoby JW, Hale TL, Jones PW, Harden PN, McCall IW:
Ultrasound measured renal length versus low dose CT vol-
ume in predicting single kidney glomerular filtration rate.
The British journal of radiology 2004, 77(921):759-764.